Pregnancy outcome after diagnosis of oligohydramnios at term
Journal Title: The New Indian Journal of OBGYN - Year 2017, Vol 4, Issue 1
Abstract
Objectives: The aim of the study was to evaluate the effects of oligohydramnios on maternal and fetal outcome at term pregnancy. Methodology: A case control study on pregnancy outcome in 100 women with AFI<5cm after 37 completed weeks of pregnancy compared with 100 controls with no oligohydramnios with matched age and parity. Results: Non stress test (NST) was non-reactive in 38% of oligohydramnios and 20% of controls and was statistically significant (P<0.05). Ominous fetal heart patterns were seen in 60% of oligohydramnios and 30% of controls but it was statistically not significant. Thick meconium stained amniotic fluid was seen in 48% of oligohydramnios and 20% of the controls and was significant (P<0.001). In oligohydramnios, 54% were induced whereas in controls, only 24% and was significant (P<0.002). For fetal distress, 88% of oligohydramnios and 90% of controls underwent LSCS and was not significant. APGAR score <7 was insignificant between the two groups. LBW and NICU admission were more in oligohydramnios and was significant (P<0.05, <0.01). Perinatal mortality was not significant between the two groups. Conclusion: Oligohydramnios (AFI<5) is valuable for predicting fetal distress in labour requiring caesarean section, used as an adjunct to other fetal surveillance methods. Oligohydramnios (AFI < 5cm) detected after 37 weeks of gestation is an indicator of poor pregnancy outcome.
Authors and Affiliations
Shiva Kumar H C Hiriyur Chidanandaiah, Chandrashekhar K, Suman Gaddi, Chandrashekhar T Tharihalli
Keywords
Related Articles
- EP ID EP452492
- DOI 10.21276/obgyn.2017.4.1.8
- Views 114
- Downloads 0
Comparative study of fetomaternal outcome using new screening criteria of serum TSH for diagnosing hypothyroidism in pregnancy
Objectives: To assess the maternal and fetal outcomes using new screening criteria with upper serum thyroid stimulating hormone (TSH) cut off as >3mIU/L, for diagnosing hypothyroidism in pregnancy. Materials and Methods:...
Elevated maternal serum alpha fetoprotein (MSAFP) level in second trimester as a screening test for predicting adverse pregnancy outcome
Objectives: To determine the sensitivity, specificity, positive predictive value and negative predictive value when elevated MSAFP level in the second trimester is used as a screening test to predict subsequent adverse p...
Placenta accreta syndrome: A rising epidemic in obstetrics
Objectives: The aims of our study were to determine incidence of placenta accreta syndrome and correlate it with the risk factors. Methods: A clinicohistopathological study had been done on the basis of clinical, radiolo...
Interesting case of invasive mole with hemoperitoneum
Trophoblastic diseases comprise a variety of biologically interrelated conditions which form a clinical spectrum from benign partial hydatidiform mole at the one end to the highly malignant choriocarcinoma at the other w...
A comprehensive overview of role of combined myoinositol and D-chiroinositol (40:1 ratio) therapy in the management of PCOS
Polycystic Ovarian Syndrome (PCOS) is one of the most common metabolic and reproductive ailment among reproductive age group women. PCOS patients present with a constellation of signs and symptoms associated with menstru...